EUVIMEDEUVIMED entdecken
Crossref

Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression

Qingsheng Xie, Jinqing Li, Jieyao Li, Chaoqun Liu, Yangyang Li, Hong Zeng, Jingwei Yu, Yingchen Wu, Kaiqian Chen, Zhaonan Zhang, Bo Wang

Modern Pathology · 2025-12 · 38 (12) · 100851

DOI: 10.1016/j.modpat.2025.100851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025-12. Verfasst von Qingsheng Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Ya…. Hauptthemen laut MEDLINE: B7 Antigens, Uterine Cervical Neoplasms, Carcinoma, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangdong Province, Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a promising next-generation immune checkpoint target. This study investigated the distribution and clinical significance of VISTA expression in cervical carcinoma. Using a cohort of 290 patients from Sun Yat-sen Memorial Hospital, we assessed VISTA expression in tumor cells, endothelial cells, and immune cells (ICs) through immunohistochemistry, and found that it was expressed in tumor cells (18.6%), endothelial cells (38.3%), and ICs (100%). Higher infiltration of VISTA+ ICs was observed in the stromal region compared with that in the intratumoral region of resectable cervical carcinoma. Among the ICs, macrophages showed the highest VISTA expression compared with that by T cells and neutrophils. High intratumoral VISTA expression was an independent marker of favorable prognosis. Robust infiltration of VISTA+ ICs and CD8+ T cells in the tumor microenvironment correlated with the best clinical outcomes. In addition, in an independent cervical carcinoma cohort (n = 48), VISTA+ ICs in both intratumoral and stromal regions were positively associated with CD8+ T cells, CD103+ T cells, and effector molecules, such as granzyme B. Elevated VISTA expression was also associated with an enriched immunosuppressive profile, including Foxp3+ regulatory T cells and molecules such as TGF-β1, PD-1, LAG-3, TIM-3, and TIGIT. Moreover, multiplex staining and correlation analysis revealed a positive association between VISTA+ TGF-β1+ ICs and FOXP3+ regulatory T cells in tumor tissues. These findings establish a strong connection between intratumoral VISTA+ ICs and a regulatory immune contexture involving both activation and suppression signatures, with a skew toward activation dominance. Our study results suggest that VISTA can be employed as a potential prognostic biomarker for cervical carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7 AntigensUterine Cervical NeoplasmsCarcinomaBiomarkers, TumorImmune ToleranceImmune EvasionHumansFemalePrognosisAdultMiddle AgedAgedFluorescent Antibody TechniqueT-LymphocytesTransforming Growth Factor beta1Tumor Microenvironment

Stichwörter der Autor:innen

VISTAcervical carcinomafavorable prognosisimmune balancemacrophages

Substanzen

VSIR protein, humanB7 AntigensBiomarkers, TumorTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Dep…
  • Division of Hematology & Oncology, Department of Geriatrics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, China.

Förderung

  • Science and Technology Planning Project of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China

Zitieren

APA

Xie, Q., Li, J., Li, J., Liu, C., Li, Y., Zeng, H., Yu, J., Wu, Y., Chen, K., Zhang, Z., & Wang, B. (2025). Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression. Modern Pathology, 38(12), 100851. https://doi.org/10.1016/j.modpat.2025.100851

Vancouver

Xie Q, Li J, Li J, Liu C, Li Y, Zeng H, et al. Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression. Modern Pathology. 2025;38(12):100851. doi:10.1016/j.modpat.2025.100851

BibTeX
@article{Xie2025,
  author = {Xie, Qingsheng and Li, Jinqing and Li, Jieyao and Liu, Chaoqun and Li, Yangyang and Zeng, Hong and Yu, Jingwei and Wu, Yingchen and Chen, Kaiqian and Zhang, Zhaonan and Wang, Bo},
  title = {Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {12},
  pages = {100851},
  doi = {10.1016/j.modpat.2025.100851}
}
Kostenlos starten →